Long Non-Coding RNA DLEU1 Up-Regulates BIRC6 Expression by Competitively Sponging miR-381-3p to Promote Cisplatin Resistance in Nasopharyngeal Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long Non-Coding RNA DLEU1 Up-Regulates BIRC6 Expression by Competitively Sponging miR-381-3p to Promote Cisplatin Resistance in Nasopharyngeal Carcinoma
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 2037-2045
Publisher
Informa UK Limited
Online
2020-03-09
DOI
10.2147/ott.s237456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis
- (2019) Yongzhi Li et al. Frontiers in Genetics
- Nasopharyngeal carcinoma
- (2019) Yu-Pei Chen et al. LANCET
- Unknown
- (2018) Clinical Respiratory Journal
- Baculoviral IAP Repeat Containing 6 (BIRC6) Is a Predictor of Prognosis in Prostate Cancer
- (2018) Wenzhen Zhuang et al. MEDICAL SCIENCE MONITOR
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer
- (2018) Jiangfeng Li et al. FASEB JOURNAL
- miR-381-3p restrains cervical cancer progression by downregulating FGF7
- (2018) Anquan Shang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3
- (2018) Tianyou Liu et al. Molecular Cancer
- DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression
- (2017) Li-Li Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL
- (2017) Sanghoon Lee et al. Oncotarget
- BIRC6 mediates imatinib resistance independently of Mcl-1
- (2017) Denis O. Okumu et al. PLoS One
- BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer
- (2016) Iris Sze Ue Luk et al. CLINICAL CANCER RESEARCH
- Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer
- (2015) Tingting Hu et al. PLoS One
- Elevated Expression of BIRC6 Protein in Non–Small-Cell Lung Cancers is Associated with Cancer Recurrence and Chemoresistance
- (2013) Xin Dong et al. Journal of Thoracic Oncology
- BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells
- (2013) Christopher G. Low et al. PLoS One
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
- (2011) Leonardo Salmena et al. CELL
- Molecular Mechanisms of Long Noncoding RNAs
- (2011) Kevin C. Wang et al. MOLECULAR CELL
- Final Stages of Cytokinesis and Midbody Ring Formation Are Controlled by BRUCE
- (2008) Christian Pohl et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started